Carcinoid Syndrome

Carcinoid syndrome is a group of symptoms that happens when certain slow-growing neuroendocrine tumors (NETs) make and release hormones—most often serotonin—into your bloodstream. These chemicals cause flushing of the skin, frequent watery diarrhea, wheezing or shortness of breath, belly pain and, over time, scarring of the right-sided heart valves (“carcinoid heart disease”). Carcinoid syndrome is most common when a mid-gut tumor (for example, in the small intestine) has spread to the liver, so the hormones can bypass the liver’s normal “filter” and circulate throughout the body. Lung NETs can also cause it because their hormones drain straight into the blood. NCBI+2cancer.gov+2

Carcinoid syndrome is a group of symptoms (most often sudden skin flushing, chronic watery diarrhea, belly cramping, wheezing, and, over time, damage to the right-sided heart valves) caused by hormone-like chemicals—especially serotonin—released by certain slow-growing neuroendocrine tumors, usually from the small intestine and often after they have spread to the liver. These chemicals enter the bloodstream and act on blood vessels, the gut, and the lungs, creating repeat attacks and long-term complications if not treated. NCBI+2NCBI+2

Neuroendocrine tumor cells make many messenger substances. Serotonin is the most important one for carcinoid syndrome. Normally, only about 1% of the amino acid tryptophan turns into serotonin, but in these tumors a lot more can be diverted, which can also reduce niacin (vitamin B3) levels and add to tiredness, rashes, or mouth soreness. Serotonin is broken down into 5-HIAA, which leaves the body in urine and is used as a test. NCBI

Other names

Carcinoid syndrome is also called “functional NET syndrome,” “serotonin syndrome of NETs” (not the same as drug-induced serotonin syndrome), and, when heart valves are involved, “carcinoid heart disease” (CaHD). NCBI+1

Types

1. Classic (mid-gut) carcinoid syndrome. This comes from NETs in the small intestine/appendix/cecum that release serotonin. People usually have pink-to-red flushing, watery diarrhea, crampy belly pain, and, in some, right-sided valve scarring over time. NCBI

2. Atypical (foregut) carcinoid syndrome. This is more often from lung or stomach NETs. Flushing can last longer and may be purplish, and diarrhea may be less dominant. Histamine and other amines—not only serotonin—play a bigger role. NCBI

3. Carcinoid syndrome without liver spread. Lung or ovarian NETs can send hormones directly into the bloodstream, or a right-to-left heart shunt can let hormones bypass the liver filter. NCBI

Common clinical patterns

1) Classic (midgut) carcinoid syndrome. Caused by small-bowel/appendiceal NETs with liver metastases. Typical features are dry, salmon-pink flushing, watery diarrhea, and wheeze. NCBI

2) Foregut carcinoid syndrome. Gastric, pancreatic, or bronchial NETs may produce less 5-HIAA and more histamine or 5-HTP, leading to flushing that is red, patchy, and sometimes itchy; diarrhea can be milder. Bronchial NETs can cause carcinoid syndrome even without liver spread due to direct drainage into the systemic circulation. NCBI+1

3) Hindgut NETs with hormonal secretion (uncommon). Rectal/colonic NETs rarely cause a full syndrome, but when they do, symptoms are usually milder unless there is extensive disease. PMC

4) Carcinoid heart disease–dominant phenotype. Some patients mainly develop right-sided valvular disease (tricuspid/pulmonic) from long-term hormone exposure, with edema, breathlessness, and a new heart murmur. PMC+1

Causes

Carcinoid syndrome is caused by hormone-secreting NETs and by circumstances that let those hormones reach the whole body. These are the key causes and permissive situations:

1. Midgut (small intestine) NET that secretes serotonin. Most common cause. NCBI

2. Appendiceal NET with functional secretion. NCBI

3. Ileal NET with high serotonin output. NCBI

4. Jejunal NET with functional secretion. PMC

5. Bronchial (lung) NET producing vasoactive amines—may cause syndrome without liver spread. NCBI

6. Gastric NET (foregut) producing histamine/5-HTP with atypical flushing. PMC

7. Pancreatic NET that secretes serotonin or other peptides. PMC

8. Ovarian NET (including strumal carcinoid) with direct systemic drainage. PMC

9. Hepatic metastases from a functional NET (most enabling factor, because liver “first-pass” metabolism is lost). NCBI

10. Extrahepatic systemic shunts (e.g., bronchial venous drainage) allowing hormones to bypass the liver. NCBI

11. Extensive tumor burden increasing total hormone release. PMC

12. Tumor secretion of multiple peptides (tachykinins, prostaglandins) that add to symptoms. NCBI

13. 5-HTP predominance in foregut tumors, causing flushing with lower urine 5-HIAA. PMC

14. Dietary tryptophan diversion by the tumor—promotes pellagra features that amplify diarrhea. NCBI

15. Mesenteric fibrosis from serotonin, causing bowel dysmotility and pain that worsen the syndrome picture. NCBI

16. Carcinoid crisis during anesthesia/surgery or with catecholamines—acute massive mediator release (a trigger-provoked cause of severe, sudden syndrome). PMC

17. Progression/poorly controlled functional NET despite therapy (biologic progression). PMC

18. Renal or hepatic impairment reducing clearance of circulating amines. PMC

19. Pregnancy or hormonal changes altering mediator metabolism (rarely reported permissive states). PMC

20. Unknown primary functional NET with liver metastases (primary not yet found). PMC

Symptoms

1) Flushing. Sudden warmth and pink-to-red discoloration of the face/upper chest; classic in midgut disease. Episodes may be triggered by stress, alcohol, or certain foods. NCBI

2) Watery diarrhea. Frequent, urgent, loose stools due to serotonin increasing intestinal secretion and motility; can lead to dehydration and electrolyte loss. NCBI

3) Wheezing or shortness of breath. Bronchospasm from circulating mediators; can mimic asthma. NCBI

4) Right-sided heart problems. Fatigue, ankle swelling, new heart murmur from scarring of tricuspid/pulmonic valves; develops with long-term exposure. PMC

5) Abdominal pain or cramping. Caused by hypermotility or mesenteric fibrosis tethering bowel loops. NCBI

6) Facial or neck warmth and flushing after alcohol or spicy foods. Food triggers are common. NCBI

7) Pellagra signs (niacin deficiency). Dry, scaly dermatitis on sun-exposed skin, diarrhea, and mood or memory changes due to tryptophan diversion. NCBI

8) Weight loss and fatigue. Related to chronic diarrhea, poor appetite, and tumor burden. PMC

9) Bloating and gassiness. From rapid transit or partial obstruction due to fibrosis. NCBI

10) Palpitations or fast heartbeat during flushes. Transient tachycardia with mediator surges. NCBI

11) Low blood pressure during attacks. Vasoactive peptides can cause hypotension. NCBI

12) Facial telangiectasias over time. Repeated flushing can leave small visible vessels on the skin. NCBI

13) Edema of legs. From right-sided valve disease or low albumin with chronic diarrhea. PMC

14) Nausea and early fullness. From altered gut motility or tumor-related factors. PMC

15) Anxiety during episodes. Catecholamine-like sensations accompany flushes for some patients. NCBI

Diagnostic tests

A) Physical examination (bedside findings)

1) Skin and face inspection. Look for active flushing, residual redness, or small dilated vessels (telangiectasia). These clues point toward a functional NET causing systemic mediator release. NCBI

2) Heart exam. Listen for a holosystolic murmur at the left lower sternal border (tricuspid regurgitation) or a systolic ejection murmur at the upper left sternal border (pulmonic valve). Right-sided murmurs suggest carcinoid heart disease in a patient with flushing/diarrhea. PMC

3) Lung exam. Wheeze, especially during an attack, supports mediator-induced bronchospasm. NCBI

4) Abdominal exam. Hepatomegaly can signal liver metastases; focal tenderness or fullness may hint at mesenteric fibrosis. NCBI

5) Nutritional status and skin. Look for pellagra-like dermatitis and signs of malnutrition from chronic diarrhea. NCBI

B) Manual or bedside functional tests (simple clinic measures)

6) Orthostatic vitals. Checking blood pressure and pulse lying and standing can show dehydration from diarrhea or vasodilatory episodes. NCBI

7) Peak expiratory flow (handheld). A quick measure of bronchospasm during symptomatic periods; reduced flow supports airway involvement. NCBI

8) Stool/flush diary. Recording frequency of diarrhea and flushes helps track severity and treatment response in daily life. PMC

9) Targeted cardiac auscultation with positional change. Listening while the patient leans forward or during inspiration can make right-sided murmurs more evident. PMC

10) Nutritional screen (Niacin risk). Simple clinic screening for dermatitis, sore mouth, or cognitive changes raises suspicion of niacin deficiency that often accompanies serotonin-producing NETs. NCBI

C) Laboratory and pathological tests

11) 24-hour urine 5-HIAA (gold-standard screening test). High levels of 5-HIAA strongly suggest a serotonin-secreting NET when symptoms fit. Patients must follow a diet avoiding serotonin-rich foods and certain drugs before and during collection to prevent false positives. Repeat testing can confirm results. CAP Documents+1

12) Plasma or serum 5-HIAA. A convenient alternative when 24-hour collection is hard or when rapid assessment is needed; interpretation should align with symptoms and imaging. Wiley Online Library

13) Chromogranin A (CgA). A general NET marker that may be elevated, but it is less specific and can rise with proton-pump inhibitors or inflammation; use alongside other tests. Academia

14) Pancreastatin or other NET peptides. Sometimes used as adjunct markers when CgA is equivocal; they support the overall picture but do not replace 5-HIAA. Academia

15) Nutritional labs. Electrolytes (for diarrhea), albumin, magnesium, and B-vitamins; consider niacin status if pellagra is suspected. Karger Publishers

16) Tumor biopsy with immunostains. Pathology confirms NET (positive synaptophysin and chromogranin) and reports Ki-67 index and mitotic rate, which classify tumor grade and guide therapy. PMC

D) Electrodiagnostic and cardiorespiratory tests

17) Electrocardiogram (ECG). May show right-sided strain or rhythm issues in advanced carcinoid heart disease; it is a baseline test in symptomatic patients. PMC

18) NT-proBNP blood test. A very useful screening biomarker for carcinoid heart disease. Values above common thresholds (e.g., ~260 ng/L in some studies) should prompt echocardiography even if there are no cardiac symptoms. American College of Cardiology+1

19) Spirometry (pulmonary function). Demonstrates reversible airflow limitation if bronchospasm is significant, supporting the syndrome’s respiratory component. NCBI

E) Imaging tests (to find and stage the tumor, and assess the heart)

20) Somatostatin-receptor PET/CT (most sensitive functional imaging). Ga-68 DOTATATE (or DOTATOC/DOTANOC) PET/CT scans detect NETs anywhere in the body by binding to somatostatin receptors on tumor cells. They outperform older octreotide scans in most settings and are FDA-approved NET imaging agents. This scan helps locate the primary, define spread, select patients for targeted treatments, and monitor disease. NETRF+3FDA Access Data+3MDPI+3

Additional structural imaging commonly used with the above: multiphasic CT or MRI of abdomen/pelvis to look for small-bowel primaries and liver metastases; echocardiography (TTE) to evaluate tricuspid/pulmonic valves for carcinoid plaques and regurgitation; CT chest for bronchial NET; and targeted endoscopy or capsule endoscopy when small-bowel disease is suspected. These tests define where the tumor is and whether the heart is affected. PMC+1

Non-pharmacological treatments (therapies & other steps)

Each item includes a short description, purpose, and how it works—in straight, simple language.

1. Avoid test-interfering foods for 5-HIAA days
   Avoid (for 72 hours before and during urine collection): bananas, plantain, pineapple, kiwi, tomatoes, eggplant, plums, walnuts, avocados; also limit certain drugs. This prevents false “high” results and helps your team make correct decisions. It works by removing extra dietary serotonin and related compounds that would otherwise raise urinary 5-HIAA. ltd.aruplab.com+2Labcorp+2

2. Everyday trigger control (food & drink)
   Many people notice flushing/diarrhea after alcohol (especially red wine), aged cheeses, smoked or pickled meats/fish, chocolate, coffee/tea, and very ripe fruit—foods rich in “amines” like serotonin, tyramine, and histamine. Avoiding or reducing these helps prevent hormone surges that cause attacks. Keep a simple food-symptom diary to spot your own triggers. News-Medical+1

3. Nutrition for diarrhea days
   Use small, frequent meals, choose lower-fat options, and separate liquids from solids if bloating is an issue. Include protein with each meal to protect weight and strength. This approach reduces gut irritation and helps hydration, which lowers diarrhea-related fatigue and cramping. Alberta Health Services

4. Oral rehydration routine
   On high-diarrhea days, sip oral rehydration solution (homemade or pharmacy) to replace salt, potassium, and fluid. This prevents dizziness, kidney strain, and muscle cramps caused by fluid loss. It works by matching water with the right salts for absorption. Alberta Health Services

5. Niacin-aware eating
   Because tumors can waste tryptophan to make serotonin, some people may develop low niacin states. Eating balanced protein and discussing B-vitamin support with your clinician can reduce mouth soreness, rash, or fatigue linked to low niacin. NCBI

6. Breath support for wheeze
   During mild wheeze, sit upright, use relaxed pursed-lip breathing, and avoid strong scents. This limits airway narrowing triggered by circulating chemicals. (Asthma-type inhalers are medications used if needed—see drug section.) NCBI

7. Stress-reduction plan
   Simple stress tools (brief mindfulness, paced breathing, gentle walks) may help because stress can trigger flushing. Short, regular practice lowers adrenaline swings that can worsen episodes. NCBI

8. Temperature and environment tips
   Heat, hot showers, and saunas may bring on flushing. Choose lukewarm water, dress in layers, and keep rooms cool to avoid vasodilation-triggered attacks. NCBI

9. Caffeine and stimulant limits
   Coffee, energy drinks, and strong tea contain vasoactive compounds that can set off flushing and palpitations. Reducing these lowers trigger load. News-Medical

10. Smoking & alcohol avoidance
    Tobacco and alcohol can provoke flushing and worsen gut and heart health. Avoiding them reduces attack frequency and protects the heart over time. News-Medical

11. Safe exercise
    Regular, moderate activity supports mood, bowels, and heart health. Start slowly and avoid very hot environments to prevent provoked flushing. Alberta Health Services

12. Skin-cooling strategies
    During a flush, a cool cloth, a fan, and hydration can shorten attacks by constricting superficial blood vessels. NCBI

13. Meal timing & texture
    Smaller meals, chewing well, and choosing cooked vegetables (instead of raw tomatoes, which can trigger some people) can ease cramping and urgency. sunnybrook.ca

14. Food safety & freshness
    Fresh meats/fish and avoiding “aged” or over-ripe foods reduce dietary amines that can intensify symptoms. sunnybrook.ca

15. Symptom diary & shared plan
    Tracking episodes, foods, and activities helps tailor your personal trigger list and supports shared decisions with your care team. Alberta Health Services

16. Heart-care follow-through
    Keeping echo appointments and reporting swelling or breathlessness early helps catch carcinoid heart disease sooner. Early care can prevent complications. American College of Cardiology+1

17. Pre-procedure planning
    Before surgery or liver procedures, teams plan octreotide support to reduce the risk of a “carcinoid crisis.” Telling all clinicians you have carcinoid syndrome is essential. PMC+1

18. Vaccination & infection-prevention basics
    Staying up to date on routine vaccines and hand hygiene lowers risk from illnesses that can worsen dehydration and stress the heart. AHA Journals

19. Reliable information sources
    Use guideline-based resources (NANETS/ENETS/ESMO) so your choices follow modern standards. nanets.net+2enets.org+2

20. Care-team coordination
    Because carcinoid syndrome touches gut, lungs, and heart, working with a multidisciplinary team (oncology, cardiology, nutrition) improves safety and outcomes. nanets.net

---

Drug treatments

Important: medications must be prescribed and monitored by your clinician. Doses below are from FDA labeling or authoritative sources where indicated.

1. Octreotide (short-acting, subcutaneous/IV)
   Class: Somatostatin analog (SSA). Typical subcutaneous doses for symptom control are individualized and may be titrated multiple times daily; IV infusions are used around procedures. Purpose: rapidly reduces flushing and diarrhea by blocking hormone release. Mechanism: binds somatostatin receptors (mainly SSTR-2/5) on tumor cells, lowering serotonin and other peptides. Common effects: injection site pain, gallstones with long-term use, abdominal discomfort; monitor glucose and gallbladder. FDA Access Data+1

2. Octreotide LAR (long-acting, IM depot)
   Class: Long-acting SSA. Usual dosing: 20–30 mg IM every 4 weeks, adjusted to symptoms. Purpose: baseline, month-to-month control of flushing/diarrhea. Mechanism: sustained SSTR binding lowers hormone release. Safety: similar SSA effects; monitor gallbladder and glucose. FDA Access Data

3. Lanreotide depot (Somatuline Depot)
   Class: Long-acting SSA. Typical dose: 120 mg deep subcutaneous every 4 weeks (label includes indications for NETs and carcinoid syndrome). Purpose: maintenance control of symptoms and tumor stabilization in many NETs. Mechanism: SSTR binding; reduces secretions and slows growth signals. Side effects: injection site reactions, gallstones, glucose changes; follow label advice (e.g., breastfeeding avoidance period). FDA Access Data

4. Telotristat ethyl (Xermelo)
   Class: Tryptophan-hydroxylase inhibitor (oral). Dose: 250 mg three times daily with food, added when SSA alone does not control diarrhea. Purpose: reduces serotonin production in the gut to cut bowel movements. Mechanism: blocks the rate-limiting step in serotonin synthesis; lowers 24-hour urinary 5-HIAA. Effects: nausea, constipation, abdominal pain; monitor liver tests. FDA Access Data+2FDA Access Data+2

5. Lutetium-177 dotatate (Lutathera) — PRRT
   Class: Radiolabeled SSA (peptide receptor radionuclide therapy). Dose: 7.4 GBq (200 mCi) IV every 8 weeks × 4. Purpose: for SSTR-positive GEP-NETs; improves tumor control and often relieves hormone symptoms. Mechanism: delivers targeted beta radiation to SSTR-expressing cells. Effects: nausea from amino acid infusion, transient bone-marrow suppression, renal dose considerations. U.S. Food and Drug Administration+2FDA Access Data+2

6. Everolimus (Afinitor)
   Class: mTOR inhibitor (oral). Dose: commonly 10 mg daily. Purpose: tumor growth control in progressive NETs (especially pancreatic NETs); indirect symptom relief by reducing tumor burden; not established for “carcinoid tumors” specifically per older labels. Mechanism: blocks mTOR pathway to slow tumor cell growth. Effects: mouth sores, infections, high blood sugar, lipid changes; careful monitoring required. FDA Access Data+1

7. Short-acting octreotide for “crisis” or procedures
   Class: SSA (IV infusion/bolus). Purpose: reduces risk and treats carcinoid crisis during anesthesia, surgery, or liver-directed therapies. Mechanism and effects as above; hospitals use protocolized infusions with boluses if instability occurs. ukinets.org+1

8. Antidiarrheals (loperamide; diphenoxylate/atropine)
   Class: Antimotility agents (OTC and Rx). Dose: per labeling. Purpose: symptomatic relief of diarrhea alongside disease-directed therapy. Mechanism: slow gut motility and increase fluid absorption. Effects: constipation, cramping; avoid excess dosing. (Use alongside SSA/telotristat when needed.) Alberta Health Services

9. Bile-acid binders (e.g., cholestyramine)
   Class: Bile-acid sequestrant. Dose: per label. Purpose: helps if bile-acid malabsorption contributes to watery stools, especially after small-bowel surgery. Mechanism: binds bile acids to reduce colonic water secretion. Effects: bloating, interference with other drugs/vitamins; space dosing. Alberta Health Services

10. H2 blockers/PPIs for acid symptoms
    Class: Acid suppression (e.g., famotidine, PPIs). Purpose: reduces acid-related discomfort, which can accompany diarrhea. Mechanism: lowers stomach acid; not disease-modifying for carcinoid syndrome itself. Effects: class-typical risks. Alberta Health Services

11. Bronchodilators for wheeze (e.g., albuterol)
    Class: Short-acting beta-agonist inhaler. Purpose: relieves episodic wheezing triggered by circulating vasoactive chemicals. Mechanism: opens airway smooth muscle. Effects: tremor, palpitations. (Directed by clinician.) NCBI

12. Interferon-alpha (selected cases)
    Class: Immunomodulator (off-label in many regions today). Purpose: may reduce hormone secretion and slow tumor growth when SSAs are insufficient and other options are unsuitable. Mechanism: antiproliferative and anti-secretory effects. Effects: flu-like symptoms, depression, cytopenias—specialist use only. MDPI

13. Pancreatic enzyme replacement (if needed)
    Class: Enzyme therapy. Purpose: helps fat digestion and reduces steatorrhea if pancreatic insufficiency or post-surgical changes coexist, improving nutrition and stool consistency. Mechanism: replaces digestive enzymes. Effects: typical GI discomfort if overdosed. Alberta Health Services

14. Antiemetics during PRRT
    Class: Antiemetic agents. Purpose: reduce nausea linked to amino-acid infusions given with Lutathera to protect kidneys. Mechanism: blocks nausea pathways. Effects: per drug class. FDA Access Data

15. Electrolyte supplements (oral potassium, magnesium as indicated)
    Purpose: correct losses from diarrhea to prevent cramps and heart rhythm issues. Mechanism: replaces deficient ions. Effects: GI upset; monitor levels. Alberta Health Services

16. Niacin (vitamin B3) supplementation when deficient
    Purpose: corrects possible niacin shortfall from tryptophan diversion to serotonin. Mechanism: replenishes vitamin B3 stores; improves related symptoms. Effects: flushing (ironic but manageable), liver enzyme monitoring for high doses. NCBI

17. Antihistamines (selected cases of flushing)
    Class: H1/H2 blockers. Purpose: may blunt histamine-mediated components of flushing in some patients. Mechanism: blocks histamine receptors; adjunct only. Effects: drowsiness (H1). News-Medical

18. Antibiotics for bacterial overgrowth (when proven)
    Purpose: if tests show small-intestinal bacterial overgrowth contributing to bloating/diarrhea, targeted courses may help. Mechanism: reduces excess bacteria and gas. Effects: class risks; only when indicated. Alberta Health Services

19. Antispasmodics (selected)
    Purpose: reduce cramping. Mechanism: relax gut smooth muscle. Effects: dry mouth, constipation—reserve for targeted symptoms under guidance. Alberta Health Services

20. Multimodal peri-anesthetic protocol (team-delivered)
    Combination of IV octreotide with anesthetic precautions reduces crisis risk during surgery or liver interventions. Effects: lowers sudden blood-pressure swings, bronchospasm, and severe flushing during procedures. PMC+1

Important clarification: Only some of the drugs above are FDA-approved specifically for carcinoid syndrome or NETs (e.g., octreotide/lanreotide, telotristat, Lutathera; everolimus is approved for certain NETs). Others are supportive or adjunct therapies used for symptoms or co-conditions; your specialist will tailor choices. FDA Access Data+4FDA Access Data+4FDA Access Data+4

---

Dietary molecular supplements

Evidence for supplements in carcinoid syndrome is limited; use only under clinician guidance and do not replace proven therapies.

1. Niacin (Vitamin B3): helps correct potential deficiency from tryptophan diversion; discuss dosing and monitoring with your clinician to avoid liver side effects and extra flushing. NCBI

2. Electrolyte powders (ORS salts): replace sodium/potassium lost in diarrhea to prevent dizziness and cramps. Alberta Health Services

3. Soluble fiber (e.g., psyllium): may firm stools and slow transit when taken with fluids; introduce slowly to avoid gas. Alberta Health Services

4. Vitamin D & calcium: support bone health when weight loss or malabsorption is present; dose per lab values. Alberta Health Services

5. Vitamin B12 (if ileal disease/resection): replaces a vitamin absorbed in the terminal ileum; helps prevent anemia/neuropathy. Alberta Health Services

6. Fat-soluble vitamins (A, E, K) when deficient: chronic diarrhea can lower absorption; replace only if labs confirm. Alberta Health Services

7. Omega-3 fatty acids: general anti-inflammatory and cardiovascular support; evidence for CS symptoms is limited. Alberta Health Services

8. Probiotics (select cases): may help some with diarrhea, but evidence in carcinoid syndrome is mixed; avoid in immunocompromise. Alberta Health Services

9. Zinc: replenishment in chronic diarrhea if low; helps taste and wound healing. Alberta Health Services

10. Multivitamin (balanced, low-amine): backs up gaps from restricted diets; choose products without added 5-hydroxytryptophan. acb.org.uk

---

Immunity booster / regenerative / stem cell drugs

There are no approved “immunity-booster,” regenerative, or stem-cell drugs for carcinoid syndrome. Current, guideline-supported treatments are somatostatin analogs, telotristat, and—in eligible SSTR-positive cases—PRRT, plus liver-directed and surgical options. Using unproven “stem-cell” or “regenerative” products risks harm and may delay effective care. Always follow NET society and oncology guidelines. nanets.net+1

---

Surgeries and procedures

1. Resection of small-bowel primary with mesenteric lymph nodes
   Surgeons aim to remove the original tumor(s), involved nodes, and fibrotic mesentery when feasible to prevent blockage/ischemia and reduce hormone load. This can improve symptoms and long-term control. PMC

2. Cytoreductive (“debulking”) liver surgery
   When many liver deposits are present, removing ≥70% of visible tumor can reduce hormone release and improve symptoms in selected people. Decision-making is individualized by NET teams. adva.nanets.net

3. Liver-directed therapies (embolization, chemoembolization, radioembolization, ablation)
   These target liver metastases by blocking tumor blood supply or heating/freezing lesions, often easing flushing and diarrhea when medication alone isn’t enough. Risks and benefits depend on liver reserve and tumor load. PMC+2Carcinoid Cancer Foundation+2

4. Valve surgery for carcinoid heart disease
   When severe right-sided valve damage causes heart failure symptoms, bioprosthetic valve replacement can restore function and relieve swelling/breathlessness. Close follow-up is essential. American College of Cardiology+1

5. Peri-operative octreotide protocol
   Before and during anesthesia or liver procedures, teams use IV octreotide to prevent carcinoid crisis (sudden unstable blood pressure, wheeze, flushing). Protocol details vary; bolus doses are given if warning signs occur. ukinets.org+1

---

What to eat & what to avoid

1. Favor fresh, non-aged foods; limit alcohol (especially red wine) and aged cheeses. News-Medical

2. Limit high-amine foods that often trigger flushing: smoked/pickled meats/fish, chocolate, very ripe fruit. News-Medical

3. On diarrhea days, choose small, low-fat meals; separate fluids from meals if bloating. Alberta Health Services

4. Consider cooked vegetables; some people avoid raw tomatoes if they trigger symptoms. sunnybrook.ca

5. Keep protein in each meal to protect weight and niacin status. Alberta Health Services

6. Hydrate with water or oral rehydration solution during flares. Alberta Health Services

7. For 5-HIAA testing days, avoid serotonin-rich foods/drugs for 72 hours (see list above). ltd.aruplab.com

8. Use a food-symptom diary to personalize triggers. Alberta Health Services

9. Be cautious with caffeine and energy drinks if they provoke flushing or palpitations. News-Medical

10. Ask for dietitian support familiar with NETs to tailor a sustainable plan. Alberta Health Services

---

Prevention

1. Identify and avoid your personal triggers (food, alcohol, heat, stress). News-Medical

2. Keep to your SSA schedule (lanreotide/octreotide) to prevent breakthrough symptoms. FDA Access Data+1

3. Add telotristat when SSA alone doesn’t control diarrhea, as your doctor advises. FDA Access Data

4. Plan procedures with an experienced NET team and peri-operative octreotide strategy. PMC

5. Stay hydrated and maintain electrolytes during flares. Alberta Health Services

6. Keep echo/NT-proBNP surveillance to catch heart valve problems early. American College of Cardiology

7. Vaccinate and practice infection prevention to avoid dehydration-worsening illnesses. AHA Journals

8. Use a medication list and alert card (note “carcinoid syndrome”) for emergencies. enets.org

9. Coordinate with a NET-literate dietitian for a balanced, low-trigger diet. Alberta Health Services

10. Rely on guideline-based centers (NANETS/ENETS/ESMO) for updates. nanets.net+1

---

When to see a doctor

Contact your care team promptly if diarrhea suddenly worsens (e.g., more than 6–8 watery stools per day), you cannot keep fluids down, you feel faint, or you notice new swelling of legs or belly, new or worse shortness of breath, or rapid weight gain—these can signal dehydration or carcinoid heart disease. Seek immediate help for severe flushing with low blood pressure, wheeze, and confusion—possible “carcinoid crisis,” especially around procedures. American College of Cardiology+1

---

FAQs

1. What causes carcinoid syndrome?
   Hormone-like chemicals (mainly serotonin) released by neuroendocrine tumors enter the blood and act on vessels, gut, and lungs. NCBI

2. Is 5-HIAA the main test?
   Yes. A 24-hour urine 5-HIAA (with 72-hour food/drug restrictions) is a key test; your team may also use blood 5-HIAA. ltd.aruplab.com

3. Why avoid certain foods before the test?
   Because some foods contain serotonin or similar amines that falsely raise 5-HIAA and can mislead decisions. ltd.aruplab.com

4. What is Ga-68 DOTATATE PET/CT?
   A scan that finds tumors with somatostatin receptors and helps plan SSA therapy and PRRT. PMC

5. What are SSAs?
   Somatostatin analogs (octreotide, lanreotide) that block hormone release and reduce flushing/diarrhea. FDA Access Data+1

6. What if SSA isn’t enough for diarrhea?
   Add telotristat ethyl to reduce serotonin production and bowel movements. FDA Access Data

7. What is PRRT (Lutathera)?
   A targeted radiotherapy that delivers radiation to receptor-positive tumors and often eases symptoms. FDA Access Data

8. Can surgery help?
   Yes. Removing the small-bowel primary/mesentery and carefully chosen liver surgery/ablation can reduce hormone load and symptoms. PMC+1

9. What is carcinoid heart disease?
   Long-term exposure to tumor chemicals can scar right-sided heart valves; echo is the main test, and some people need valve replacement. PMC+1

10. Do I need a special diet?
    A balanced plan with attention to your personal triggers, hydration, and adequate protein is best; work with a NET-aware dietitian. Alberta Health Services

11. Does caffeine or alcohol matter?
    Yes—both can trigger flushing in some people; limiting or avoiding them can reduce attacks. News-Medical

12. Is everolimus for carcinoid syndrome?
    It’s approved for some NETs (e.g., pancreatic NETs) to slow growth; it may indirectly help symptoms by shrinking/stabilizing tumors but isn’t a primary anti-diarrheal. FDA Access Data

13. Are “stem-cell” treatments recommended?
    No. There are no approved stem-cell/regenerative drugs for carcinoid syndrome; stick to guideline-supported therapies. enets.org

14. What about antihistamines?
    They may help histamine-related flushing in some people but are adjuncts, not a replacement for SSA/telotristat. News-Medical

15. How often should my heart be checked?
    Your team will individualize it; many patients with active syndrome or high 5-HIAA need regular echo and NT-proBNP monitoring. American College of Cardiology

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 10, 2025.

PDF Documents For This Disease Condition References